2025-03-05 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Review

**0. Summary of Key Figures:**

* **Cumulative Return (ISRG):** 301.93%
* **Cumulative Return (VOO):** 108.99%
* **Return Difference (ISRG - VOO):** 192.9%
* **Relative Return Difference:** 86.7% (indicates ISRG significantly outperformed VOO historically, within the range of its historical performance relative to VOO)
* **Current Price:** $557.96
* **RSI:** 33.89 (suggests oversold conditions)
* **PPO:** -0.91 (indicates bearish momentum)
* **Expected Return (vs. S&P 500):** 24.1% (long-term, 2+ years)

**1. Performance Comparison and Company Overview:**

Intuitive Surgical Inc. is a leading developer and provider of robotic-assisted surgery systems.  The cumulative return of ISRG (301.93%) significantly outperforms the S&P 500 (VOO) return of 108.99% over the analyzed period. The substantial difference highlights ISRG's superior performance. The relative return difference of 86.7% places ISRG's performance in the upper echelon of its historical performance relative to VOO, though this is not a guarantee of future outperformance.


**Alpha and Beta Analysis:**

The provided data shows high CAGR (Compound Annual Growth Rate) across various periods, indicating strong historical growth. However, the Beta values fluctuate, suggesting sensitivity to market conditions varies over time.  The positive Alpha values in recent years (2019-2025)  indicate outperformance relative to the market benchmark. The high MDD (Maximum Drawdown) in some periods highlights the risk associated with investing in ISRG. Market capitalization has consistently increased over the analyzed period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.4 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.3 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.3 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.2 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.6 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.3 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 186.2 |
| 2023-2025  | 196.0% | 9.9% | 146.0% | 0.8 | 199.0 |


**2. Recent Price Action:**

* **Closing Price:** $557.96
* **5-Day Moving Average:** $568.56
* **20-Day Moving Average:** $586.06
* **60-Day Moving Average:** $564.03

The price is below all three moving averages, suggesting a potential downward trend.  The recent price change (-1.59%) indicates a minor decline.


**3. Technical Indicators and Expected Return:**

* **RSI (33.89):**  Indicates oversold conditions, potentially suggesting a bounce is possible.
* **PPO (-0.91):** Shows negative momentum, aligning with the downward trend observed in the moving averages.
* **Delta_Previous_Relative_Divergence (-2.9):**  Confirms short-term bearish momentum.
* **Expected Return (2+ years):** A 24.1% excess return over the S&P 500 is projected for long-term investors.  This projection should be considered cautiously,  as it's just an estimate and not a guarantee.  The recent price drop may slightly reduce this expected return, but long-term growth projections still remain positive.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-18 | 1.59 | $2.04 B     |
| 2024-07-19 | 1.48 | $2.01 B     |
| 2024-04-19 | 1.54 | $1.89 B     |
| 2023-10-20 | 1.18 | $1.74 B     |
| 2024-10-18 | 1.18 | $1.74 B     |

There seems to be a duplicate entry for October 18, 2024.  Excluding the duplicate, revenue shows a general upward trend, though EPS fluctuates. Further analysis is needed to determine the underlying reasons for these fluctuations.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B  | 68.04%       |
| 2024-09-30 | $2.04B  | 67.41%       |
| 2024-06-30 | $2.01B  | 68.30%       |
| 2024-03-31 | $1.89B  | 65.87%       |
| 2023-12-31 | $1.93B  | 66.24%       |

Revenue shows a consistent growth trend over the period, alongside relatively stable high profit margins.


**Capital and Profitability:**

| Quarter | Equity   | ROE    |
|---------|----------|--------|
| 2024-12-31 | $16.43B | 4.17%  |
| 2024-09-30 | $15.58B | 3.63%  |
| 2024-06-30 | $14.71B | 3.58%  |
| 2024-03-31 | $13.96B | 3.90%  |
| 2023-12-31 | $13.31B | 4.56%  |

Equity is increasing steadily, though ROE fluctuates but remains relatively stable.


**6. Overall Analysis:**

ISRG has demonstrated strong historical performance, significantly outperforming the S&P 500. While recent price action shows a downward trend, technical indicators suggest potential oversold conditions.  The company's financial statements reveal consistent revenue growth and high profit margins. However, investors should consider the volatility inherent in ISRG's stock price and the risks associated with its past high maximum drawdowns. The projected long-term return remains positive, but this should be viewed as a potential outcome, not a guaranteed result.  Further fundamental and technical analysis is recommended before making any investment decisions.  The relatively high expected return is attractive but should be weighed against the risk profile of the stock, which is suggested by its relatively high maximum drawdown values.
